Glycomine

Replacement Therapies for Rare Diseases| PMM2-CDG | Glycomine

We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.

Company details

Address: San Carlos, United States
Website: glycomine.com

Reviews

No reviews yet.

All reviews of Glycomine · Write a review

Domain and WHOIS record

Domain: glycomine.com
Registrar: eNom, LLC
Registered: 26 May 2013
Expires: 26 May 2027
Record updated: 19 May 2026
Name servers: dns1.name-services.com, dns2.name-services.com, dns3.name-services.com, dns4.name-services.com, dns5.name-services.com
DNSSEC: Not signed

WHOIS record for glycomine.com

Sign up for Signalsant to see verified emails, phone numbers and the full company record.